Urology · Charleston, SC
NPI
1871592089
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1470 Tobias Gadson Blvd, Suite 201
Charleston, SC, 29407
Phone (843) 556-7060
Groups this clinician bills Medicare through
Medicare paid, 2024
$231K
6,473 services
Medicare patients, 2024
723
Average age 77
Drug cost, 2024
$1.8M
1,266 prescriptions
Company payments, 2025
$1,612
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander W Ramsay was code 81002 (clinical chemistry), 1,199 times for 558 patients. In total Alexander W Ramsay billed 6,473 services in 81 codes, and Medicare paid $231K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81002 Clinical Chemistry | Office | 1,199 | 558 | $3.39 | $4,070 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,020 | 533 | $11.12 | $11K |
| 99213 Office E&M - Established | Office | 923 | 510 | $58.75 | $54K |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 756 | 14 | $45.92 | $35K |
| 99214 Office E&M - Established | Office | 421 | 280 | $84.26 | $35K |
| 36415 Venipuncture Blood Collection | Office | 329 | 224 | $8.65 | $2,846 |
| 51798 Ultrasound - Nonspecific | Office | 261 | 180 | $7.23 | $1,887 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 192 | 54 | $46.15 | $8,861 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 93 | 48 | $35.00 | $3,255 |
| 51741 Test - Miscellaneous | Office | 76 | 76 | $7.11 | $541 |
| 51728 Other Organ Systems | Office | 62 | 62 | $152.51 | $9,455 |
| 52000 Cystourethroscopy | Office | 56 | 44 | $154.32 | $8,642 |
| 99211 Office E&M - Established | Office | 47 | 47 | $15.97 | $750 |
| 99232 Hospital E&M - Subsequent | Facility | 35 | 16 | $58.92 | $2,062 |
| 99204 Office E&M - New | Office | 26 | 26 | $107.54 | $2,796 |
By year: 2022 $214K for 8,422 services; 2023 $214K for 6,050 services; 2024 $231K for 6,473 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 1,199 | 558 | $3.39 | $4,070 |
| 36415 Venipuncture Blood Collection | 329 | 224 | $8.65 | $2,846 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander W Ramsay prescribed most often to Medicare patients was Tamsulosin Hcl, with 405 prescriptions and refills. In total Alexander W Ramsay wrote 1,266 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 405 | 991 | 124 | $7,685 |
| Finasteride Generic | 111 | 303 | 37 | $1,629 |
| Xtandi Enzalutamide | 79 | 79 | Under 11 | $1.1M |
| Orgovyx Relugolix | 68 | 68 | Under 11 | $181K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 63 | 94 | 32 | $1,861 |
| Solifenacin Succinate Generic | 63 | 135 | 20 | $2,899 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 59 | 75 | 31 | $217 |
| Myrbetriq Mirabegron | 50 | 94 | 16 | $42K |
| Ciprofloxacin Hcl Generic | 38 | 38 | 31 | $109 |
| Gemtesa Vibegron | 26 | 56 | Under 11 | $26K |
| Cephalexin Generic | 24 | 25 | 20 | $182 |
| Dutasteride Generic | 24 | 71 | Under 11 | $953 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 24 | 68 | Under 11 | $470 |
| Prednisone Generic | 20 | 22 | Under 11 | $158 |
| Abiraterone Acetate Generic | 19 | 19 | Under 11 | $99K |
Brand drugs: 284 claims; generic drugs: 982 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander W Ramsay $1,612 ($1,612 in general payments such as food, travel and fees) from 24 companies. The largest payer was Olympus America Inc. with $223.
| Company | Payments | Amount |
|---|---|---|
| Olympus America Inc. | 9 | $223 |
| Boston Scientific Corporation BSX | 4 | $164 |
| Ferring Pharmaceuticals Inc. | 5 | $138 |
| Janssen Biotech, Inc. JNJ | 1 | $115 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $113 |
| Astellas Pharma US Inc 4503.T | 3 | $95.66 |
| Bioprotect Medical, Inc. | 2 | $93.24 |
| Dendreon Pharmaceuticals LLC | 3 | $75.84 |
| Abbvie Inc. ABBV | 4 | $69.87 |
| Endo USA, Inc. | 3 | $67.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.